Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Exchange Rate Effect (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Exchange Rate Effect for 15 consecutive years, with $100000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 114.29% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $800000.0, a 180.0% increase, with the full-year FY2025 number at $800000.0, up 180.0% from a year prior.
  • Exchange Rate Effect was $100000.0 for Q4 2025 at Myriad Genetics, down from $600000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.2 million in Q3 2024 to a low of -$800000.0 in Q1 2024.
  • A 5-year average of -$42105.3 and a median of $100000.0 in 2021 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 600.0% in 2022, then crashed 500.0% in 2024.
  • Myriad Genetics' Exchange Rate Effect stood at $100000.0 in 2021, then surged by 600.0% to $700000.0 in 2022, then changed by 0.0% to $700000.0 in 2023, then crashed by 200.0% to -$700000.0 in 2024, then surged by 114.29% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Exchange Rate Effect are $100000.0 (Q4 2025), $600000.0 (Q2 2025), and $100000.0 (Q1 2025).